Goldline Pharmaceutical Ltd 52 Week High
Goldline Pharmaceutical Ltd
NSE: GLPL
YEARHIGH
Key Highlights
- The 52 Week HIGH of Goldline Pharmaceutical Ltd is ₹ 60 as of 28 Jul 26 .
Company Fundamentals for Goldline Pharmaceutical Ltd
Market Price of Goldline Pharmaceutical Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 28 Jul 2026 | 37.66 |
| 27 Jul 2026 | 38.37 |
| 24 Jul 2026 | 38.13 |
| 22 Jul 2026 | 39.99 |
| 21 Jul 2026 | 41 |
| 20 Jul 2026 | 40.09 |
| 17 Jul 2026 | 40.49 |
| 16 Jul 2026 | 39.05 |
| 15 Jul 2026 | 39.02 |
| 14 Jul 2026 | 38.84 |
Asset Value vs Market Value of Goldline Pharmaceutical Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Goldline Pharmaceutical Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Goldline Pharmaceutical Ltd
Historical Net Profit of Goldline Pharmaceutical Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Goldline Pharmaceutical Ltd
Goldline Pharmaceutical Ltd News Hub
BSE SME Goldline Pharmaceutical delivers a dose of listing gains
The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stoc
Read more
19 May 26
Goldline Pharmaceutical to discuss results
Goldline Pharmaceutical will hold a meeting of the Board of Directors of the Company on 9 June 2026.
Read more
03 Jun 26
